Cell Counting Market Size & Share, by Product (Instruments, Spectrophotometers, Flow Cytometers, Hemocytometers, Reagents, Microplates); End-user (Pharmaceutical Companies, Hospitals, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3546
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Cell Counting Market size is estimated to cross USD 24 Billion by the end of 2035, growing at a CAGR of 12% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of cell counting was over USD 8 Billion. The growth of the market can be attributed to the rising incidence of chronic diseases. The rising demand for biologics for the treatment of chronic illnesses is predicted to increase further in the years to come. For instance, different cell counting tools are employed during the creation of biologics. Further, an increase in the consumption of unhealthy foods, and rising stress levels among people across the globe are also expected to add to the market growth. As per estimates, more than 50% of individuals in the US had at least one chronic illness in 2018.

In addition to these, factors that are believed to fuel the market growth of cell counting include the growing popularity of cell counting instruments. For instance, the use of cell counting tools is expanding across a wide range of academic fields, including neurology, cancer biology, and immunology. Further, they are widely utilized in cancer research. Additionally, the growing technological advancements in cell counting devices are predicted to present the potential for market expansion over the projected period.


Cell Counting Market
Get more information on this report: Request Free Sample PDF

Cell Counting Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Prevalence of Infectious Diseases – On account of the increasing population density, the market is expected to expand more in the upcoming years. As of 2018, more than 30% of people in India had infectious illnesses.

  • Rising Geriatric Population – Elderly population is more prone to chronic illness, which is estimated to drive market growth. The percentage of individuals over 60 in the world will nearly double from 12 to 22% between 2015 and 2050.

  • Rising Number of Blood-Related Problems – Specific nutrient deficiency resulting from poor diet, and unhealthy lifestyle among people, is estimated to drive the market growth.  Further, blood problems are caused by a variety of factors, such as genes, side effects of certain drugs, and other illnesses. In Australia, blood cancer and other associated blood illnesses are predicted to claim the lives of over 5,000 persons in 2022.

  • Increasing Health Spending – According to the most recent expenditure data, health spending in the US rose by over 9% in 2019.

  • Surging Incidences Target Diseases such as HIV – HIV (human immunodeficiency virus) targets immune system cells. After being diagnosed with HIV, the CD4+ cell count is routinely assessed. An immunosuppressed state from HIV is indicated by a low CD4 level, which is anticipated to drive market growth. It was discovered that there were over 38 million HIV-positive individuals worldwide in 2021.

Challenges

  • Exorbitant Cost of Cell Analysis - The high cost of automated cell counting technologies, is one of the major factors predicted to slow down the market growth. For instance, many are unable to afford cell counting techniques for medical or research purposes owing to the high prices of the apparatus, equipment, and procedures.
  • Lack of Knowledgeable Medical Professionals
  • Absence of Knowledge

Cell Counting Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~12%

Base Year Market Size (2022)

~ USD 8 Billion

Forecast Year Market Size (2035)

~ USD 24 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Cell Counting Segmentation

End-user (Pharmaceutical Companies, Hospitals, Research Institutes)

The global cell counting market is segmented and analyzed for demand and supply by end users into pharmaceutical companies, hospitals, research institutes, and others. Out of the four segments, the research institutes segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing research in stem cells. For instance, stem cell treatment has emerged as a very promising and sophisticated scientific research issue, it is believed that these may one day be used to cure severe ailments including paralysis and Alzheimer’s treatment. Further, widespread usage of cell counting in cancer research, and in other areas is anticipated to create numerous opportunities for the growth of the segment in the coming years. Between 2018 and 2022, there were over 500 publications on stem cell precision medicine research.

Product (Instruments, Spectrophotometers, Flow Cytometers, Hemocytometers, Reagents, Microplates)

The global cell counting market is also segmented and analyzed for demand and supply by-products into instruments, spectrophotometers, flow cytometers, hemocytometers, reagents, and microplates. Amongst these six segments, the reagents segment is expected to garner a significant share. Fluorescence-based cell counting reagents are used for precise cell counting. Further, purchasing reagents regularly for use in automated cell counting, flow cytometry, and spectrophotometry is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

      By Product

  • Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Hemocytometers
  • Reagents
  • Microplates

        By End User

  • Pharmaceutical Companies
  • Hospitals
  • Research Institutes
  • Others
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cell Counting Industry - Regional Synopsis

APAC Market Statistics

The Asian Pacific cell counting market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the increasing cases of cancer. Low blood counts are most frequently a side effect of chemotherapy in cancer patients, which is expected to boost the demand for cell counting in the region. A full cell count can assist assess whether or not a patient's disease will progress under certain conditions. Cell counting is also used for determining primary tumors, circulating tumors, and others. Further, the expanding use of stem cell treatment in nations including China, Japan, India, and others, is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry is also anticipated to boost market growth during the forecast period. As per data, in Southeast Asia, there were over 150 thousand new cases of breast cancer in 2020.

North American Market Forecast

The North American cell counting market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the growing prevalence of cardiovascular and blood disorders. Almost half of all Americans suffer from cardiovascular disease, which can be brought on by factors including diabetes, smoking, high blood pressure, poor diet, and inactivity. Many risk factors for cardiovascular disease are connected to WBC count, which is anticipated to increase the region's demand for cell counting. For instance, smokers have a greater WBC count, which increases the risk of dying from coronary heart disease. Further, the increasing focus on medical research aimed at enhancing techniques to determine the number of cells in the human body is also anticipated to contribute to the market growth in the region.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing frequency of chronic illnesses. The use of biologics to treat chronic illnesses is becoming more popular in the region. The usage of cell counting tools, including flow cytometers and spectrophotometers, helps in regulating the cell content in biologics. In addition, immune health in patients is also indicated by their CD4 cell count. Further, the rising government funding and efforts for cancer research, are also anticipated to contribute to the market growth in the region. In addition, the surging adoption of cell counting devices in various areas of research such as immunology, cancer biology, and neuroscience in the region, is also anticipated to boost the market growth during the forecast period.

Research Nester
Cell Counting Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Cell Counting Landscape

top-features-companies
    • Merck KgaA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Perkin Elmer Inc.
    • Olympus Corporation
    • Tecan Trading AG
    • Abbott Laboratories
    • General Electric Company
    • Boule Diagnostics AB
    • Becton, Dickinson, and Company
    • Sysmex Corporation

In the News

  • Becton, Dickinson, and Company introduced BD FACSymphony A1 Cell Analyzer, which provides labs of all sizes access to powerful flow cytometry capabilities. Further, it is a fluorescence-activated cell analyzer that provides cutting-edge research capabilities in a small-footprint design, making it easier for more labs to obtain instruments for difficult scientific research.

  • Sysmex Corporation, a leading diagnostic solutions provider, received FDA approval for residual white blood cell counts, which will be added to its XN-10 Automated Hematology Analyzer with Blood Bank mode. Further, this analyzer offers residual white blood cell counts, red blood cell (RBC), and platelet (PLT) component testing in a single sample aspiration.

Author Credits:  Radhika Pawar


  • Report ID: 3546
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of infectious diseases, and surging incidences of target diseases such as HIV are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

Exorbitant cost of cell analysis, and lack of knowledge are estimated to be the growth-hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Merck KgaA, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Olympus Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, end-user, and by region.

The research institutes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Cell Counting Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying